Aceso Life Science (00474) Announces Upcoming Board Meeting on 28 November 2025

Bulletin Express

Nov 14

Aceso Life Science Group Limited (Stock Code: 00474) has scheduled a board meeting on 28 November 2025 at 11:00 a.m. in Wan Chai, Hong Kong. The primary objectives include approving the unaudited interim results for the six months ended 30 September 2025 and considering the possibility of an interim dividend. The meeting will be held at Rooms 2501–2509, 25/F, Shui On Centre, 6–8 Harbour Road.

According to the announcement, the board of directors currently comprises two executive directors, one non-executive director, and three independent non-executive directors. Final decisions regarding interim results adoption and any potential dividend will be disclosed to the public following the meeting as scheduled.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1105131050"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105131050\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105131050?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105131050","market":"hk","top_or_hot":-1,"title":"Aceso Life Science (00474) Announces Upcoming Board Meeting on 28 November 2025","media":"Bulletin Express","content":"<p>Aceso Life Science Group Limited (Stock Code: 00474) has scheduled a board meeting on 28 November 2025 at 11:00 a.m. in Wan Chai, Hong Kong. The primary objectives include approving the unaudited interim results for the six months ended 30 September 2025 and considering the possibility of an interim dividend. The meeting will be held at Rooms 2501–2509, 25/F, Shui On Centre, 6–8 Harbour Road.</p>\n<p>According to the announcement, the board of directors currently comprises two executive directors, one non-executive director, and three independent non-executive directors. Final decisions regarding interim results adoption and any potential dividend will be disclosed to the public following the meeting as scheduled.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aceso Life Science (00474) Announces Upcoming Board Meeting on 28 November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAceso Life Science (00474) Announces Upcoming Board Meeting on 28 November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-14 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aceso Life Science Group Limited (Stock Code: 00474) has scheduled a board meeting on 28 November 2025 at 11:00 a.m. in Wan Chai, Hong Kong. The primary objectives include approving the unaudited interim results for the six months ended 30 September 2025 and considering the possibility of an interim dividend. The meeting will be held at Rooms 2501–2509, 25/F, Shui On Centre, 6–8 Harbour Road.</p>\n<p>According to the announcement, the board of directors currently comprises two executive directors, one non-executive director, and three independent non-executive directors. Final decisions regarding interim results adoption and any potential dividend will be disclosed to the public following the meeting as scheduled.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00474","symbol_name":"信铭生命科技","start_time":0,"source_url":"","article_id":"1105131050","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105131050","pubTimestamp":1763114709,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Aceso Life Science Group Limited (Stock Code: 00474) has scheduled a board meeting on 28 November 2025 at 11:00 a.m. in Wan Chai, Hong Kong. The primary objectives include approving the unaudited...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00474":"信铭生命科技"},"translate_title":"Aceso Life Science(00474)宣布即将于2025年11月28日召开董事会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00474":1},"content_text":"Aceso Life Science Group Limited (Stock Code: 00474) has scheduled a board meeting on 28 November 2025 at 11:00 a.m. in Wan Chai, Hong Kong. The primary objectives include approving the unaudited interim results for the six months ended 30 September 2025 and considering the possibility of an interim dividend. The meeting will be held at Rooms 2501–2509, 25/F, Shui On Centre, 6–8 Harbour Road.\nAccording to the announcement, the board of directors currently comprises two executive directors, one non-executive director, and three independent non-executive directors. Final decisions regarding interim results adoption and any potential dividend will be disclosed to the public following the meeting as scheduled.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}